This specific ISBN edition is currently not available.View all copies of this ISBN edition:
In this hard-hitting indictment of the pharmaceutical industry, Ray Moynihan and Allan Cassels show how drug companies are systematically using their dominating influence in the world of medical science, drug companies are working to widen the very boundaries that define illness. Mild problems are redefined as serious illness, and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD.
Selling Sickness reveals how expanding the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt national healthcare systems all over the world. This Canadian edition includes an introduction placing the issue in a Canadian context and describing why Canadians should be concerned about the problem.
"synopsis" may belong to another edition of this title.
Ray Moynihan has covered the business of health care for more than a decade with the Australian Broadcasting Corporation, the Australian Financial Review, and the British Medical Journal. He is an award-winning journalist and the author of four books, including Selling Sickness, which has been translated into a dozen languages. Moynihan lives in Byron Bay, Australia.
Alan Cassels is a drug policy researcher at the University of Victoria, in British Columbia, and is the co-author (with Ray Moynihan) of the international bestseller Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning Us All into Patients.From Publishers Weekly:
This accessible study about the collusion between medical science and the drug industry emphasizes how drug companies market their products by either redefining problems as diseases (like female sexual dysfunction) or redefining a condition to encompass a greater percentage of the population. Moynihan, a health journalist for the New England Journal of Medicine and the Lancet, and Cassels, a Canadian science writer, note, for instance, that eight of the nine specialists who wrote the 2004 federal guideline on high cholesterol, which substantially increased the number of people in that category, have multiple financial ties to drug manufacturers. Physicians now routinely prescribe cholesterol-lowering pills (statins) that may have perilous side effects, when many people could lower their risk of heart attack with less costly and dangerous steps, such as exercise and improved diet. Through aggressive merchandising, funding of medical conferences and expensive perks, drug companies win doctors over to diagnosing these "diseases" and prescribing drugs for them. Unfortunately for these authors, much of this territory has been covered by several books in the past year, most notably Marcia Angell's The Truth About the Drug Companies
Copyright © Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.
"About this title" may belong to another edition of this title.
Book Description Douglas & Mcintyre Ltd, 2006. Paperback. Condition: New. Seller Inventory # DADAX1553652177
Book Description Douglas & McIntyre Ltd, 2006. Condition: New. book. Seller Inventory # M1553652177